Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yasushi Fuchimoto, Christene A. Huang, Kazuhiko Yamada, Akira Shimizu, Hiroshi Kitamura, R.B. Colvin, Vincent Ferrara, Michael C. Murphy, Megan Sykes, Mary White-Scharf, David M. Neville Jr., David H. Sachs
Published in Volume 105, Issue 12
J Clin Invest. 2000; 105(12):1779–1789 doi:10.1172/JCI8721
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 7

(a) Plasma creatinine levels of single haplotype–mismatched chimeric re cipients that received donor MHC-matched kidney allografts without immunosuppression: Animals no. 13101 and no. 13476 were chimeric animals that received donor MHC-matched kidney allografts; animal no. 10653 was a naive animal that received a single haplotype–mismatched kidney allograft. (be) Donor-specific tolerance and immunocompetence of single haplotype–mismatched chimeric animal no. 13101: CTL responses of a naive SLAad animal (b) and of animal no. 13101 before PBSCT (c); after PBSCT, but before kidney transplantation (KTx) (d); and after KTx (e). Each graph shows anti-self SLAad (open squares), anti-donor SLAac (closed squares), and anti–third-party Yucatan miniature swine (open triangles) response.